Search Clinical Trials Search
Clinical Trials
× ...
Sort & Filter
Sort by
Specialty

Disease or Condition

Age Group


Drug/Medication


152 results found


Lung

ECOG/ACRIN, EA5231, Ph3, Rand, NSCLC, durvalumab +/- AZD6738 (ceralasertib)

Primary Objective 2.1.1 The primary objective will be to assess for improvement in disease free survival (DFS) in patients who do not achieve pCR (pathologic complete response) following neoadjuvant therapy and patients who receive adjuvant combination ...


Lung

SWOG, S2414, Ph3, randomized, NSCLC, durvalumab (MEDI4736) versus surveillance.

Primary Objective: To compare disease free survival (DFS) in stage II-IIIB non-small cell lung cancer participants who achieved a pathologic complete response (pCR) following standard of care neoadjuvant chemo-immunotherapy and are randomized to adjuvant ...